Human Pathology
Volume 41, Issue 9 , Pages 1238-1244 , September 2010

T-cell leukemia 1 expression in nodal Epstein-Barr virus–negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma

  • Gabriela Gualco, MD

      Affiliations

    • Consultoria em Patologia, Botucatu, SP 18602-010, Brazil
    • ,
  • Lawrence M. Weiss, MD

      Affiliations

    • Division of Pathology at the City of Hope National Medical Center, Duarte, CA 91010, USA
    • ,
  • Glen N. Barber, PhD

      Affiliations

    • University of Miami Miller School of Medicine and Sylvester Cancer Center, Fogarty International Center, Miami, FL 33136, USA
    • ,
  • Carlos E. Bacchi, MD

      Affiliations

    • Consultoria em Patologia, Botucatu, SP 18602-010, Brazil
    • Corresponding Author InformationCorresponding author. Consultoria em Patologia Rua Major Leônidas Cardoso 739 Botucatu, SP 18602-010, Brazil.

Received 3 December 2009 ,Revised 14 January 2010 ,Accepted 22 January 2010.

References 

  1. Narducci MG, Pescarmona E, Lazzeri C, et al. Regulation of TCL1 expression in B-and T-cell lymphomas and reactive lymphoid tissues. Cancer Res. 2000;60:2095–2100
  2. Herling M, Patel KA, Hsi ED, et al. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage. Am J Surg Pathol. 2007;31:1123–1129
  3. Virgilio L, Lazzeri C, Bichi R, et al. Deregulated expression of TCL1 causes T-cell leukemia in mice. Proc Natl Acad Sci U S A. 1998;95:3885–3889
  4. Said JW, Hoyer KK, French SW, et al. TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. Lab Invest. 2001;81:555–564
  5. Fu TB, Virgilio L, Narducci MG, Facchiano A, Russo G, Croce CM. Characterization and localization of the TCL-1 oncogene product. Cancer Res. 1994;54:6297–6301
  6. Hoyer KK, French SW, Turner DE, et al. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci U S A. 2002;99:14392–14397
  7. Rodig SJ, Vergilio JA, Shahsafaei A, Dorfman DM. Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation. Am J Surg Pathol. 2008;32:113–122
  8. Aggarwal M, Villuendas R, Gomez G, et al. TCL1A expression delineates biological and clinical variability in B-cell lymphoma. Mod Pathol. 2009;22:206–215
  9. Nakayama I, Murao S, Kitazawa S, Azumi A, Yamamoto M, Maeda S. Activation of the TCL1 protein in B-cell lymphomas. Pathol Int. 2000;50:191–199
  10. Virgilio L, Narducci MG, Isobe M, et al. Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci U S A. 1994;91:12530–12534
  11. Kiss C, Nishikawa J, Takada K, Tcell leukemia I. Oncogene expression depends on the presence of Epstein Barr virus in the virus carrying-Burkitt lymphoma lines. PNAS. 2003;100:4813–4818
  12. In:  Swerdlow SH,  Campo E,  Harris NL,  Jaffe ES,  Pileri SA,  Stein H,  Thiele J,  Vardiman JW editor. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008;
  13. Oschlies I, Klapper W, Zimmermann M, et al. Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood. 2006;107:4047–4052
  14. Miles RR, Raphael M, McCarthy K, et al. SFOP/LMB96/CCG5961/UKCCSG/NHL 9600 Study Group Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group. Pediatr Blood Cancer. 2008;51:369–374
  15. Gualco G, Weiss LM, Harrington WJ, Bacchi CE. Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome. Am J Surg Pathol. 2009;33:1815–1822
  16. Heerema NA, Bernheim A, Lim MS, et al. State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY. Pediatr Blood Cancer. 2005;45:616–622
  17. McClure RF, Remstein ED, Macon WR, et al. Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol. 2005;29:1652–1660
  18. Akasaka T, Akasaka H, Ueda C, et al. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene. J Clin Oncol. 2000;18:510–518
  19. Calvo K, Traverse A, Pittaluga S, Jaffe E. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma. Adv Anat Pathol. 2004;11:227–238
  20. Johnson P, Davies A. Primary mediastinal B-cell lymphoma. Hematology Am Soc Hematol Educ Program. 2008;349–358
  21. Bacchi MM, Bacchi CE, Alvarenga M, Miranda R, Chen YY, Weiss LM. Burkitt's lymphoma in Brazil: strong association with Epstein-Barr virus. Mod Pathol. 1996;9:63–67
  22. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–282
  23. Chuang S, Ye H, Du MQ, et al. Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern. Am J Clin Pathol. 2007;128:558–564
  24. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–511
  25. Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871–3879
  26. Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851–862
  27. Liu YH, Xu FP, Zhuang HG, et al. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients. Hum Pathol. 2008;39:875–884
  28. Kuraishy AI, French SW, Sherman M, et al. TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation. Proc Natl Acad Sci U S A. 2007;104:10175–10180
  29. Lones MA, Raphael M, Perkins SL, et al. Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical quality. J Pediatr Hematol Oncol. 2006;28:568–574
  30. Lones MA, Perkins SL, Sposto R, et al. Large-cell lymphoma arising in the mediastinum in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol. 2000;18:3845–3853
  31. Bell A, Rickinson A. Epstein-Barr virus, the TCL-1 oncogene and Burkitt lymphoma. Trends Microbiol. 2003;11:496

PII: S0046-8177(10)00055-9

doi: 10.1016/j.humpath.2010.01.015

Human Pathology
Volume 41, Issue 9 , Pages 1238-1244 , September 2010

Article Tools

* Image Usage & Resolution